Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelinesRichard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Breast cancer version 3.2014William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 21, 2015
An international study to increase concordance in Ki67 scoringMei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research DirectionsRyan J O Dowling, Joseph A Sparano, Pamela J Goodwin, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical ConsiderationsRyan J O Dowling, Kevin Kalinsky, Daniel F Hayes, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
NPJ Breast Cancer|July 20, 2017
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaborationSamuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelinesRichard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Breast cancer version 3.2014William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 21, 2015
An international study to increase concordance in Ki67 scoringMei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research DirectionsRyan J O Dowling, Joseph A Sparano, Pamela J Goodwin, et al.
JNCI Cancer Spectrum|April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical ConsiderationsRyan J O Dowling, Kevin Kalinsky, Daniel F Hayes, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
NPJ Breast Cancer|July 20, 2017
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaborationSamuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 27